A AB BS S T TR RA AC CT T O Ob b j je ec c t ti i v ve e: : The p53 tu mo ur sup pres sor ge ne plays an im por tant ro le in the re gu la ti on of cell pro li fe ra ti on. It is lo ca ted on the short arm of the 17th chro mo so me. It has 11 exons and en codes for a tu mor sup pres sor pro te in cal led p53 which is 53kD in we ight and 393 ami no acids in length. This pro te in, a trans crip ti on fac tor, is an im por tant re gu la tor of cell cycle. Up to da te, a num ber of mu ta ti ons (75 % of which are fo und bet we en co don 26 and 332) ha ve be en de tec ted on p53 ge ne. Recent re se arc hes sho wed that lung ne op lasm re sul ting from the mu ta ti ons of p53 ge ne va ri ed bet ween 33% (ade no car ci no ma) and 70% (small cell lung can cer), and it is re por ted that the hot spots were ma inly fo und at the co dons 175, 248, and 273. M Ma a t te e r ri i a al l a an nd d M Me et t h ho od ds s: : In this study, the exons, exonin tron junc ti ons, and so me in tron re gi ons, which are lo ca ted bet we en exon 4-9 of p53 ge ne, of 24 pati ents who had a sur gi cal ope ra ti on du e to a lung mass we re exa mi ned by au to ma tic DNA se qu en cing in Uni ver sity of Le ip zig. R Re e s su ul lt ts s: : 53 mis sen se and 7 fra mes hift mu ta ti ons we re de tec ted bet we en 4 th and 9 th exons (Co dons 36-318) of 18 samp les among the 24 samp les. Fifty five of the se mu ta ti ons were he te rozy go us, and five of them were ho mozy go us. Si mi larly, 12 mis sen se mu ta ti ons de tec ted as a re sult of the se ri al analy ses of the re gi on bet we en in trons 4-9, and seven of them we re he te rozy gous and 5 we re ho mozy go us. C Co on nc c l lu u s si i o on n: : So me re se arch re gar ding p53 ge ne re por ted that co don 175, 248, and 273 were hot spots and mu ta ti ons were fre qu ent in the se co dons. Ho we ver we ha ve not seen any mu ta ti ons in any of the se co dons in our study. Nuc le o ti de chan ges at the po si ti ons 13432 (5' be gin ning) and 13999 (3' en ding) of 6th in tron, which are very im por tant re gi ons, may re sult in the for ma ti on of an ab nor mal pro te in. We sup po se that ot her nuc le o ti de chan ges are not very im por tant du e to the ir he te rozy go us na tu re and lo ca ti on. K Ke ey y W Wo or rd ds s: : Lung ne op lasms; ge nes, p53; se qu en ce analy sis, DNA Ö ÖZ ZE ET T A Am ma aç ç: : p53 tü mör bas kı la yı cı ge ni hüc re ço ğal ma sı nın dü zen len me sin de önem li rol oy nar. 17. kro mo zo mun kı sa ko lun da yer leş miş tir. 11 ek so nu var dır ve 53 kD ağır lı ğın da ve 393 ami noasit uzun lu ğun da olan p53 şek lin de isim len di ri len bir tü mör bas kı la yı cı ge ni şif re ler. Bir trans krip si yon fak tö rü olan bu pro te in hüc re dön gü sü nün önem li bir dü zen le yi ci si dir. Bu gü ne ka dar p53 ge nin de (%75'i ko don 26 ve 332 ara sın da olan) bir ta kım mu tas yon lar sap tan mış tır. Son za man lar da ya pı lan araş tır ma lar gös ter miş tir ki p53 ge nin de ki mu tas yon lar dan kay nak la nan ak ci ğer kit le le ri %33 (adeno kar si nom) ile %70 (kü çük hüc re li ak ci ğer kan se ri) ara sın da de ği şir ve so run lu böl ge le rin baş lı ca ko don 175, 248 ve 273'de ol du ğu bil di ril miş tir. G Ge e r re eç ç v ve e Y Yö ön n t te em m l le er r: : Bu ça lış ma da ak ci ğer de kit le ta nı sıy la cer ra hi gi ri şim uy gu la nan 24 has ta nın p53 ge ni nin 4-9. ek son la rı na lo ka li ze ek son lar, ekson-in tron bi leş ke le ri ve ba zı in tron böl ge le ri Le ip zig Üni ver si te si'n de oto ma tik DNA se kan sı ile değer len di ril di. B Bu ul l g gu u l la ar r: : Yir mi dört ör ne ğin 18'inin 4. ve 9. ek son la rı ara sın da (ko don 36-318) 53 yan lış an lam mu tas yo nu ve 7 çer çe ve kay ma sı mu tas yo nu sap tan dı. Bu mu tas yon la rın 55'inin hete ro zi got, 5'inin ho mo zi got ol du ğu bu lun du. Ben zer şekil de, 4-9. in tron lar ara sın da ki böl ge nin seri in ce le me le ri so nu cun da sap ta nan 12 an lam kay ma sı mu tas yo nun dan 7'si he te ro zi got, 5'i ho mo zi got tu. p53 ge ni ile il gi li ba zı araş tır ma lar da ko don 175, 248 ve 273'ün so run lu böl ge ler oldu ğu ve bu ko don lar da mu tas yon la rın sık gö rül dü ğü bil di ril miş tir. Fa kat biz ça lış ma mız da bu kodon la rın hiç bi rin de mu tas yo na rast la ma dık. S So o n nu uç ç: : Çok önem li böl ge ler olan al tın cı in tro nun 13432 (5' baş lan gıç) ve 13999. (3' bi tiş) po zis yon la rın da nük le o tid de ği şik lik le ri anor mal bir pro te i nin orta ya çık ma sıy la so nuç la na bi lir. He te ro zi got ol ma la rı ve yer le şim le ri ne de niy le di ğer nük le o tid deği şik lik le ri nin çok önem li ol ma dı ğı nı dü şü nü yo ruz. 
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MATERIAL AND METHODS

TISSUE SAMPLES
Informed consent was obtained from each patient (The study was approved by the Çukurova University Ethics Committee on March 4, 2003, Assembly number: 3). Cancerous lung tissue samples from 24 patients, who were diagnosed by lung mass and operated surgically at University of Çukurova, Faculty of Medicine, Thoracic and Cardiovascular Surgery Department, were used. The samples were put into 70% ethanol and stored at -20°C. DNA isolations from the tissue samples were performed according to the modified method of Sambrook et al. 34 
POLYMERASE CHAIN REACTION (PCR) AMPLIFICATION
Primers used separately amplify exons 4 to 9 of p53 gene and synthesized using a Applied Biosystem UK (Warrington) ( Table 1) .
PCR amplifications of the exons were carried out according to reaction mixture conditions given in Table 2 .
DNA SEQUENCING
All PCR products were purified with Qiagen purification kit and sequenced by Applied Biosystem model 377 automated sequencer (PE Biosystems, Foster City, CA, USA) using 2 µl of the products. The sequencing results were controlled in comparison with reference serials obtained from p53 data bank (GI:35213) employing "align two sequences" software at http://blast.ncbi.nlm.nih.gov/Blast.cgi.
RESULTS
The list of the mutations, which are determined as a result of sequence analysis, was given in Table 3 and 4. Missense mutations were found between codons 36 and 123 of exon 4 (Table 3) . Fourteen mutations were found between codons 134-149 of exon 5, of these mutations 11 were heterozygote missense and 3 were homozygote frameshift mutations (Codon 145 CTG →-TG, C →del) (Table 3, Figure 1 ). Four mutations were found between codons 187-218 of exon 6, 3 of them were heterozygote missense and one of them was a homozygote frameshift mutation (Codon 189 GCC → -CC, G → del) (Table 3) . Five mutations were found between codons 225-252 of exon 7, 4 of these mutations were heterozygote missense and one of them was a heterozygote frameshift mutation (Codon 245 GCC → AGGC, A→ ins) (Table 3, Figure 1 ). Nine mutations were found between codons 261-262 of exon 8, 7 of these mutations were heterozygote missense, and 2 of them were heterozygote frameshift mutations (Codon 262 GGT → GG-, T →del) ( Table 3) . For exon 9, only one heterozygote missense mutation was found in codon 318 (Table 3 In this study, intron regions (intron 4-8) were also analysed in terms of mutations. It was found that there were totally 12 nucleotide changes in various parts of 4 th and 7 th intron. Although, 7 of the changes were found as heterozygote and 5 of them were found as homozygote form. It was found that nucleotide changes at the positions 13432 th and 13999 were the beginning and ending points of the 6 th intron. It was found that the other nucleotide changes detected were located at the inner parts of the intron (Table 4) . 
FI GU RE 2:
He te rozy go us mis sen se mu ta ti on; at exon 4 co don 74: GCC→ GTC, exon 8 co don 267: CGG→CGT and exon 9 co don 318: CCA→CCG.
tivity, because virtually all the oligomers will contain at least one defective subunits and such oligomers can not function as transcriptions factors. Oncogenic p53 mutations act dominantly in negative allele carries for the point mutation. 36 Due to the fact that, the mutations found in the exon 4 were heterozygote missense mutations; we suppose that they are not the primary effect on the formation of the tumour. However, they are significant, because it is reported that this region is very important part (DNA binding part) of p53 protein, therefore, allele loss is effective in the formation of a tumour. [24] [25] [26] 35 Thus, we believe that it is of great importance as it is reported that mutations occurred in this region are effective in the loss of p53 function. [1] [2] [3] [4] [5] [6] In some patients homozygous frameshift mutation occured because of Cytosine deletion (CTG→-TG, C→del) in the 145 th position of codon site leading to a stop codon at position 157. The reason is that this mutation results in frameshift, and thus, the p53 protein to be formed will be rather different. Although, mutation rate in codon 144 was reported to be higher in the previous studies 37, 38 we have found 2 mutations in heterozygote forms in this codon in our study. Nevertheless, 9 mutations between codon 144-149 show that this region is exposed to mutations and therefore it is also very important. Formation of heterozygote missense mutation in codon 187 of exon 6 (GGT→ GAG, T→del A→ins) may not be as important as the homozygote frameshift mutation.
In addition the other homozygous frameshift mutations occured because of Guanine deletion (GCC→-CC, G→del) at position 189 of the codon site which does not lead to any stop codon but different aminoacid sequence until the end of exon only for one patient. Likewise, we believe that insertion of Adenine between codons 244 and 245 in exon 7 (GGC GGC→ GGC A GGC, A→ins) and deletion of Timine in codon 262 of exon 8 (GGT→GG-, T→del) results in frameshift, though it was in heterozygote formation, which is an important factor in the formation of the tumour. Although, some researches regarding p53 gene reported that codon 175, 248, and 273 are hot spots and mutations are frequently seen in these codons, 28, 30 we have not seen any mutations in any of these codons in our study. 
